News (75)

Transcript : Aadi Bioscience, Inc., Q1 2024 Earnings Call, May 08, 2024
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO) PR
Transcript : Aadi Bioscience, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa PR
Transcript : Aadi Bioscience, Inc. - Special Call
Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations PR
Transcript : Aadi Bioscience, Inc., Q3 2023 Earnings Call, Nov 08, 2023
Transcript : Aadi Bioscience, Inc., Q2 2023 Earnings Call, Aug 09, 2023
Transcript : Aadi Bioscience, Inc., Q1 2023 Earnings Call, May 10, 2023
Transcript : Aadi Bioscience, Inc., Q4 2022 Earnings Call, Mar 28, 2023
Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology Annual Meeting on Women's Cancer AQ
Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women's Cancer PR
Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society 2022 Annual Meeting AQ
Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting PR
Transcript : Aadi Bioscience, Inc., Q3 2022 Earnings Call, Nov 09, 2022
Transcript : Aadi Bioscience, Inc., Q2 2022 Earnings Call, Aug 10, 2022
Aadi Bioscience : Corporate Overview PU
Aadi Bioscience : Corporate Overview PU
Transcript : Aadi Bioscience, Inc., Q1 2022 Earnings Call, May 12, 2022
Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders AQ
Aadi Bioscience Announces First Patient Dosed in its PRECISION 1 Phase 2 Registrational Trial of nab-Sirolimus in Patients with Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 and TSC2 Genes AQ
AADI BIOSCIENCE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K) AQ
Aadi Bioscience : Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update - Form 8-K PU
Aadi Bioscience : Corporate Overview PU
Aadi Bioscience : Corporate Overview PU
Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update - Form 8-K PU
Aadi Reports Third Quarter 2021 Financial Results and Provides Business Update AQ
Aadi Bioscience : Appoints Loretta Itri as Chief Medical Officer AQ
Aadi Bioscience, Inc. Appoints Loretta Itri as Chief Medical Officer CI
Gilead Sciences : Advances Oncology Portfolio with New Data from Phase 3 ASCENT Trial of Trodelvy in Metastatic Triple Negative Breast Cancer AQ
Gilead Sciences : Advances Oncology Portfolio With New Data From Phase 3 ASCENT Trial of Trodelvy® in Metastatic Triple Negative Breast Cancer BU
Immunomedics : Announces FDA Orphan Drug Designation of Trodelvyᵀᴹ for Glioblastoma PU
Immunomedics : Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma AQ
Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™ for Adult and Pediatric Glioblastoma GL
Transcript : Immunomedics, Inc. - Special Call
Immunomedics : Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvyᵀᴹ in Metastatic Urothelial Cancer PU
Immunomedics : Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer AQ
Immunomedics Announces Positive Results from Pivotal Phase 2 TROPHY U-01 Study of Trodelvy™ in Metastatic Urothelial Cancer GL
Immunomedics : Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer AQ
Trodelvy™ Significantly Extends Survival in Phase 3 ASCENT Study of Metastatic Triple-Negative Breast Cancer GL
Immunomedics : Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers AQ
Immunomedics Announces Encouraging Early-Stage Clinical Results with Trodelvy™ in Brain Cancers GL
Transcript : Immunomedics, Inc., Q2 2020 Earnings Call, Aug 05, 2020
Immunomedics : Expands Collaboration with Roche Evaluating TrodelvyTM PU
Immunomedics Expands Collaboration with Roche Evaluating Trodelvy™ (sacituzumab govitecan-hziy) in Combination with Tecentriq® (atezolizumab) into Urothelial and Non-Small Cell Lung Cancers GL
12NextSee all

Companies (2)

MERCHANT HOUSE INTERNATIONAL LIMITED 3 M $
Logo Merchant House International Limited

Merchant House International Limited is a designer, manufacturer and marketer of leather boots and shoes, home and seasonal decorative items, and home textile. The Company operates in four segments: Home textile manufacturing, Home textile trading, Footwe ...

VMS INDUSTRIES LIMITED 8 M $
Logo VMS Industries Limited

VMS Industries Limited is an India-based company, which is engaged in the business of ship breaking as well as trading in ferrous and non-ferrous metals. The Company's segments include Manufacturing and Trading. The Manufacturing segment is engaged in shi ...


Insiders

Picture Loretta Itri
Loretta Itri

Loretta M. Itri is Chief Medical Officer of Immunomedics, Inc. In the past she held the position of Chief Medical Officer at Genta, Inc., Senior Vice President-Medical & Regulatory Affairs at Robert Wood Johnson Pharmaceutical Research Institute, Chief Medical Officer & Senior VP-Clinical Affairs at Ortho Biotech Products LP, Senior Director-Clinical Investigations at Hoffmann-La Roche, Inc., EVP-Global Health Science & Regulatory Affairs at The Medicines Co. and Member-Scientific Counselor at National Cancer Institute. Dr. Itri received a doctorate from New York Medical College and an undergraduate degree from Long Island University.


Picture Loretta Cecil
Loretta Cecil

Loretta A.
Cecil
is currently the Director at GenapSys, Inc. and a Member at The Phi Beta Kappa Society.
She previously worked as the Senior Vice President-Governance Relations at McKesson Corp., Chief Compliance Officer & General Counsel at NCR Voyix Corp., and General Counsel at Mckesson Technology Solutions.
She was also a Member at Womble Bond Dickinson (US) LLP.
From 2017 to 2022, she served as the Executive Vice President & General Counsel at Change Healthcare, Inc. Ms. Cecil holds a graduate degree from The University of North Carolina at Chapel Hill and an undergraduate degree from The University of North Carolina at Greensboro.


Picture Loretta Marcoccia
Loretta Marcoccia

Loretta Marcoccia holds the position of Chief Operating Officer & EVP-Global Banking at The Bank of Nova Scotia. Ms. Marcoccia is also on the board of Women in Capital Markets. She received an undergraduate degree from the University of Toronto.


Picture Loretta Yuen
Loretta Yuen

Loretta Yuen occupies the position of EVP, Head-Group Legal & Regulatory Compliance at Oversea-Chinese Banking Corp. Ltd. She received a graduate degree from National University of Singapore.


Picture Ben Itri
Ben Itri

Ben Itri currently works at IQ-Analog Corp., as Director.






Picture Lorettta M. Itri
Lorettta M. Itri

Lorettta M.
Itri
currently works as a Director at The American-Italian Cancer Foundation.



Picture Rich Itri
Rich Itri

Rich Itri currently works as a Director & Chief Innovation Officer at Eze Castle Integration, Inc.



Picture Lucio Antonio Itri
Lucio Antonio Itri

Lucio Antonio Itri is the founder of Bitdrome Srl.


Picture Loretta M. Auer
Loretta M. Auer

Loretta M.
Auer
worked as a Director of Information Systems at LeBoeuf, Lamb, Greene & MacRae LLP from 1992 to 2001, and at Webster & Sheffield LLP from 1985 to 1990.
She was also a Principal at Ernst & Young LLP (Missouri) in 1992, and a Team Leader of Process, Standards & Systems at Blue Cross & Blue Shield Association from 1972 to 1977.
Auer served as the Chief Information Officer at Fish & Richardson PC.
She earned an undergraduate degree from Immaculata University.




Picture Loretta McCarthy
Loretta McCarthy

Loretta McCarthy is currently the Co-CEO & Managing Partner at Golden Seeds LLC, Director at Prolitec, Inc., and Principal at McCarthy Group LLC.
Her former positions include Director at Carnegie Speech Co., Inc., Director at New Yorkers for Children, Vice President-Industry Marketing at American Express Co., and Chief Marketing Officer at OppenheimerFunds, Inc. She holds an undergraduate degree from the University of Arizona and an MBA from the University of Colorado.




Picture Loretta Easton
Loretta Easton

Loretta Easton is currently the Director at Progressive Redevelopment, Inc. She is also a Member at The Urban Land Institute and the National Apartment Association.
Previously, she worked as the Chief Development Partner at Julian LeCraw & Co. LLC.
Ms. Easton completed her undergraduate degree at Elgin Community College.

































Picture Loretta A. Kelemen
Loretta A. Kelemen

Loretta A.
Kelemen
is currently the Vice President-Operations at Owl International, Inc. She has an undergraduate degree from Valdosta State University and graduate degrees from Air War College and Air Force Institute of Technology.


Picture Loretta Jobs
Loretta Jobs

Loretta Jobs currently holds a position as a trustee at Murray-Calloway County Hospital.




Picture Loretta R. Whitehead
Loretta R. Whitehead

Loretta R.
Whitehead
currently works at East Tennessee Realtors, as Member, South Carolina Association of Realtors, as Member, and Central Carolina Association of Realtors, as Member.
Ms. Whitehead also formerly worked at Lexington Medical Center Foundation, as Chairman, First Community Corp.
(South Carolina), as Independent Director from 2011 to 2015, and First Community Bank (Lexington, South Carolina), as Director.
Ms. Whitehead received her undergraduate degree in 1963 from Columbia College (SC).








Picture Loretta Lee
Loretta Lee

Loretta Lee has a current job as the Head of China Business at Invest Hong Kong Ltd.




Picture Loretta E. Foley
Loretta E. Foley

Loretta E.
Foley
worked as a Vice President-Business Process at United Rentals, Inc., a Senior Auditor at KPMG LLP, and a Senior Manager-Financial Communications at Kraft Foods International, Inc.




Picture Loretta Smith
Loretta Smith

Loretta Smith currently works at Child Action, Inc., as Director.






Picture Loretta P. Mayer
Loretta P. Mayer

Loretta P.
Mayer
was the founder of SenesTech, Inc. founded in 2004, where she held the title of Director in 2019.
She was the Chief Executive Officer of Binnacle Development Inc. from 1978 to 1991 and Vice President of Soroptimist International of the Americas, Inc. from 1990 to 1991.
Dr. Mayer received her graduate degree in 1997 and doctorate in 2000 from Northern Arizona University and her undergraduate degree in 1971 from the University of California San Diego.




Picture Loretta Lang
Loretta Lang

Loretta Lang has a current job as a Partner at Hengeler Mueller Partnerschaft von Rechtsanwälten mbB.









Picture Loretta Goldenberg
Loretta Goldenberg

Loretta Goldenberg currently holds a Director position at The First National Bank & Trust Co. of Miami (Oklahoma).


Picture Loretta P. Dodgen
Loretta P. Dodgen

Loretta P.
Dodgen
, who previously worked as a Director at Integrity Financial Corp.
(North Carolina) and Christian Blind Mission International USA.






Picture Loretta Wojtak
Loretta Wojtak

Loretta Wojtak currently works at U-Haul International, Inc., as Principal.




Picture Loretta L. Doan
Loretta L. Doan

Loretta L.
Doan
is currently the Vice President-Policy & Global Affairs at American Association for Clinical Chemistry, Inc. She completed her undergraduate degree at Indiana University and her doctorate at the University of Louisville.






No results for this search